Cargando…
Long-term prognostic value of macrophage migration inhibitory factor in ST-segment elevation myocardial infarction patients with metabolic syndrome after percutaneous coronary intervention
Metabolic syndrome (MetS) is a major risk factor for cardiovascular disease and negatively affecting the prognosis of patients with ST elevation myocardial infarction (STEMI). Macrophage migration inhibitory factor (MIF) is a multipotent cytokine involved in various cardiovascular and inflammatory d...
Autores principales: | Yu, Xiao-Lin, Zhao, Qian, Liu, Fen, Yuan, Yu-Juan, Fang, Bin-Bin, Zhang, Xue-He, Li, Wen-Ling, Li, Xiao-Mei, Du, Guo-Li, Gao, Xiao-Ming, Yang, Yi-Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403533/ https://www.ncbi.nlm.nih.gov/pubmed/36035926 http://dx.doi.org/10.3389/fcvm.2022.947395 |
Ejemplares similares
-
Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study
por: Yu, Xiao-Fan, et al.
Publicado: (2022) -
Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Zhao, Li-Hong, et al.
Publicado: (2022) -
Effect of optimized thrombus aspiration on myocardial perfusion and prognosis in acute ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention
por: Xu, Boning, et al.
Publicado: (2023) -
Plasma Exosome miRNAs Profile in Patients With ST-Segment Elevation Myocardial Infarction
por: Guan, Ruicong, et al.
Publicado: (2022) -
Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock
por: Wu, Jing, et al.
Publicado: (2022)